Table 1 below shows the baseline characteristics of patients enrolled in the A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI Study published in NEJM on Sept. 3, 2019. Looking the same research paper at Table 1, what statistical test can be likely used to compare the mean age in the genotype-guided vs. standard-treatment groups